COMPARISON OF CA19-9 WITH OTHER TUMOR-MARKERS IN THE DIAGNOSIS OF CANCER OF THE PANCREAS

被引：47

作者：

SATAKE, K ^{[1
]}

TAKEUCHI, T ^{[1
]}

机构：

[1] TOKYO WOMENS MED COLL,INST GASTROENTEROL,TOKYO 162,JAPAN

来源：

PANCREAS | 1994年 / 9卷 / 06期

关键词：

PANCREATIC CANCER; CA19-9; SPAN-1; DUPAN-2; CARCINOEMBRYONIC ANTIGEN;

D O I：

10.1097/00006676-199411000-00008

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The carbohydrate antigen 19-9 (CA19-9) and radioimmunoassay have been shown to offer new hope for improving the diagnosis of pancreatic cancer, and various tumor markers (including SPan-1, DUPAN-2, and CA50) have been established. While clinical studies of these markers have found satisfactory sensitivities, only a few studies have compared these tumor markers on the same blood samples. We therefore evaluated the clinical efficacy of SPan-1, CA19-9, DUPAN-2, CA50, carcinoembryonic antigen, and Elastase 1 in detecting pancreatic cancer in identical blood samples.

引用

页码：720 / 724

页数：5

共 13 条

[1]

BELL JS, 1985, GASTROENTEROLOGY, P3877

[2]

CHANG JH, 1990, J JPN PANCREAS SOC, V5, P80

[3]

CHO M, 1986, JPN J PANC SOC, V1, P69

[4]

CHUNG YS, 1987, CANCER, V60, P1636, DOI 10.1002/1097-0142(19871001)60:7<1636::AID-CNCR2820600736>3.0.CO

[5]

2-C

[6]

CHUNG YS, 1986, J JPN SURG SOC, V87, P236

[7]

DELVILLANO BC, 1983, CLIN CHEM, V29, P549

[8] MONOCLONAL-ANTIBODIES AGAINST GASTROINTESTINAL TUMOR-ASSOCIATED ANTIGENS ISOLATED AS MONOSIALOGANGLIOSIDES [J].

LINDHOLM, L ;

HOLMGREN, J ;

SVENNERHOLM, L ;

FREDMAN, P ;

NILSSON, O ;

PERSSON, B ;

MYRVOLD, H ;

LAGERGARD, T .

INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1983, 71 (02) :178-181

[9]

METZGAR RS, 1982, CANCER RES, V42, P601

[10]

OKURA H, 1987, PHARM MED, V5, P21

← 1 2 →